Document 54n7QK82v6d8jQ4vBj1y6Qp4

FILE NAME: Johnson & Johnson (JAJ) DATE: 1974 Dec 17 DOC#: JAJ009 DOCUMENT DESCRIPTION: Letter from J&J to Dr. Estrin & Dr. Menkart RE Talc xAm M J^km rni HEALTH CARE DIVISION G. LEE f r o m . Mr. Wallace H. Steinberg t o . Dr, Norman F, Estrin (C.T.F.A.) Dr. John Menkart (Clairol, Inc.) SUBJ: TALC o a t h December 17, 1974 The talc task force has completed the process of development of analytical procedures for determining the presence of chrysotile and tremolite in talc. We believe it is critical for the C.T.F.A. to now recommend these methods to the F.D.A. before the art advances to more sophisticated techniques with higher levels of sensitization. At this time, Pfizer and Whittaker, Clark and Daniels have delayed supporting the recommendation until they can confirm the reliability of the technique. Both companies have requested and received a two month delay, which we consider reasonable. Any further delays without good justification, we would oppose because delays in our recommendation to the F.D.A. can move us to a less favorable time for review. I recommend this subject be added to our January 8 Agenda because of its critical timing, ..and_a-lso-that_Mr .^Sandland be invited for an up-to-date report. "Wallace H. Steinberg Director of Development Health Care Division cjb cc: Mr. G. Sandland (Bristol-Myers) Mr. R, C. Stites M r . J. W. Melton bcc; Dr. L. L. Kaplan Mr. G. Lee Dr; D. R, Pexte-r-son ---,- --- Protected Document-Subject to Protective Order